The Best of Canadian Science and Technology
Beacon Securities analyst Gabriel Leung thinks the new acquisition by VitalHub (VitalHub Stock Quote, Chart, News TSXV:VHI) should be immediately … [Read more...] about VitalHub earns bullish new price target from Beacon Securities
Mackie Research launched coverage on Wednesday on drug developer Algernon Pharmaceuticals (Algernon Pharmaceuticals Stock Quote, Chart, News CSE:AGN) … [Read more...] about Algernon Pharmaceuticals has big upside, says Mackie Research
Following the company's second quarter results, Desjardins analyst David Newman has hiked his price target on WELL Health Technologies (WELL Health … [Read more...] about Desjardins raises price target on WELL Health to $5.00
A quarter he describes as a "blowout" has Echelon Capital analyst Andrew Semple giving Trulieve Cannabis (Trulieve Cannabis Stock Quote, Chart, News … [Read more...] about Trulieve Cannabis gets new price target from Echelon after “blowout” quarter
Clarus Securities analyst Noel Atkinson thinks there is huge upside in StageZero Life Sciences (StageZero Life Sciences Stock Quote, Chart, News … [Read more...] about StageZero Life Sciences has a massive upside, Clarus Securities says
Following second quarter results he described as strong, National Bank Financial analyst Richard Tse has raised his price target on Docebo (Docebo … [Read more...] about Docebo gets new $60.00 price target at National Bank
Better than expected first quarter results have National Bank Financial analyst Richard Tse raising his price target on Lightspeed POS (Lightspeed POS … [Read more...] about Lightspeed POS earns bullish new target at National Bank
Ahead of second quarter earnings from Celestica (Celestica Stock Quote, Chart, News TSX:CLS) analyst Paul Treiber of RBC Capital is sticking with his … [Read more...] about Take a pass on Celestica, says RBC Capital
Interested in a Canadian telco during COVID-19? It’s not a bad play, says portfolio manager Lorne Steinberg, but you’re likely to do better with … [Read more...] about BCE is a better bet than Rogers, this fund manager says
Investors burned by the year-long slump in cannabis will be happy to hear that things are looking up for cannabis stocks —in the US, at least. … [Read more...] about American cannabis stocks are looking cheap, Stifel says
